logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Regenerx Biopharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 50.0



Forward Citations = 17

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Allan L Goldstein (9 out of 24 patents)

silverMedal David Crockford (6 out of 9 patents)

bronzeMedal Gabriel Sosne (3 out of 4 patents)

4.  Jack Finkelstein, Jr (2 out of 2 patents)

5.  Christian B Allan (1 out of 19 patents)

6.  Michelle Wheater (1 out of 1 patent)

7.  Hynda K Kleinman (1 out of 6 patents)

8.  Katherine M Malinda (1 out of 4 patents)

9.  William H Walton (1 out of 3 patents)

10.  Jack Jr Finkelstein (0 patent)

11.  Jack Finkelstein (0 patent)

12.  JJ Finkelstein (0 patent)


12 patents:

1. 10004785 - LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized (2018-06-26),
2. 9821030 - LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized (2017-11-21),
3. 9585941 - Eye drop formulation (2017-03-07),
4. 9504730 - Method of achieving a thymosin beta 4 concentration in a human patient (2016-11-29),
5. 9056087 - Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives (2015-06-16),
6. 8716215 - Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease (2014-05-06),
7. 8426365 - Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure (2013-04-23),
8. 8399609 - Treating or preventing extracellular matrix build-up (2013-03-19),
9. 8399412 - Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions (2013-03-19),
10. 8383576 - LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized (2013-02-26),
11. 8143218 - Treatment of skin, and wound repair, with thymosin beta 4 (2012-03-27),
12. 8093214 - Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure (2012-01-10),
Company Overview
Regenerx Biopharmaceuticals, Inc. is a biotechnology company based in Rockville, Maryland, focused on the development of innovative therapeutics for tissue regeneration and repair. The company specializes in the research and application of regenerative medicine, particularly in the areas of wound healing and neuroprotection. By leveraging its proprietary technologies, Regenerx aims to address unmet medical needs and improve patient outcomes through advanced biopharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#58 in Rockville, MD

#354 in Maryland

#25,589 in US

#48,235 in the World

Rockville, MD (US)
Rockville, MD, United States of America

Regenerx Biopharmaceuticals, Inc.

Forward Citations = 17

9 inventors:

goldMedal Allan L Goldstein (9 out of 24 patents)

silverMedal David Crockford (6 out of 9 patents)

bronzeMedal Gabriel Sosne (3 out of 4 patents)

4.  Jack Finkelstein, Jr (2 out of 2 patents)

5.  Christian B Allan (1 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Regenerx Biopharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/regenerx-biopharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…